Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature

Recruiting now

Conditions studied: Growth Hormone Deficiency, Idiopathic Short Stature, Turner Syndrome, Small for Gestational Age

In brief

This study evaluates long-term safety and effectiveness of Growtropin®-II treatment in children with short stature.

Key facts

Study ID

NCT04798690

Run by

Dong-A ST Co., Ltd.

People needed

5000

Starts

2021-02-08

Expected to finish

2035-02-01

Last updated by the study team

2026-07-21

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children with short stature by growth hormone deficiency(GHD) or idiopathic short stature (ISS) or turner's syndrome(TS) or small for gestational age(SGA)
• Children who has official height record at least 6 months prior

You may not qualify if…

• Children with Epiphyseal closure

Where it is running

• Yonsei University Health System, Severance Hospital — Seoul, Seodaemun-gu, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.